Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/CTRI/2024/08/072515
CTRI/2024/08/072515Not yet recruitingPhase 4

Comparison of Dexmedetomidine and Dexamethasone used as an Adjuvant to Ropivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block.

Dr Umesh N P1 site in 1 country60 target enrollmentStarted: August 20, 2024Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 4
Status
Not yet recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
To compare the onset and duration of motor and sensory block between dexmedetomidine and dexamethasone as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus block.
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Study is initiated to compare the onset and duration of motor and sensory block between dexmedetomidine and dexamethasone as an adjuvant to ropivacaine in ultrasound guided supraclavicular brachial plexus block will be assesed and recorded and to compare the sedation, duration of analgesia, side effects during the study

Study Design

Study Type
Interventional
Allocation
Na
Masking
None

Eligibility Criteria

Ages
18.00 Year(s) to 70.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •1.Patients of both sexes aged ≥18 yrs.
  • •2.Patients undergoing elective upper limb surgeries.
  • •3.ASA-PS I and II patients.
  • •4.Patients who are willing to participate in the study with informed consent.

Exclusion Criteria

  • •1.Infection at site of injection.
  • •2.Patients who have peripheral neuropathy.
  • •3.Presence of 1st,2nd and 3rd degree heart block.
  • •4.Patients who are pregnant.
  • •5.Patients who have coagulopathies.
  • •6.Patients who have allergy or hypersensitivity to local anaesthetic drugs.

Outcomes

Primary Outcomes

To compare the onset and duration of motor and sensory block between dexmedetomidine and dexamethasone as an adjuvant to ropivacaine in ultrasound-guided supraclavicular brachial plexus block.

Time Frame: 24 HOURS

Secondary Outcomes

  • 1.To compare the sedation during intraoperative period.(2.To compare the duration of analgesia in post operative period.)

Investigators

Sponsor
Dr Umesh N P
Sponsor Class
Other [self]
Responsible Party
Principal Investigator
Principal Investigator

Dr Umesh N P

Mandya institute of medical sciences

Study Sites (1)

Loading locations...

Similar Trials

Not yet recruiting
Phase 1/2
How Adding Dexmedetomidine and Dexamethasone to Levobupivacaine Can Improve Pain Relief in Arm Nerve Blocks. How Adding Dexmedetomidine and Dexamethasone to Levobupivacaine Can Improve Pain Relief in Arm Nerve Blocks
CTRI/2025/03/081904Gandhi Medical College60
Not yet recruiting
Phase 2
To access in lower limbs surgeries done under spinal anaesthesia by hyperbaric levobupivacaine, will IV infusion of dexmedetomidine affect the analgesia .
CTRI/2025/08/093869Adesh university50
Completed
Phase 4
Comparing Doses of Intrathecal Dexmedetomidine
NCT07395271Bahria International Hospital60
Not yet recruiting
Not Applicable
A study to compare the effects of Dexamethasone and Dexmedetomidine when added to local anesthetics for pain relief during upper limb surgeries using an ultrasound-guided nerve block.
CTRI/2025/07/091909Dr KOUSIKA K98
Recruiting
Not Applicable
Dexamethasone, Dexmedetomidine and Their Combination on Post op. GIT Function Measured by I-FFED Score Post Laparoscopic Cholecystectomy
NCT07329933Benha University160